Indications and uses
temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive
temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive
do not use more than directed take every 4 hours. Do not take more than 6 packets in 24 hours. Age Dose adults and children 12 years of age and over one packet children under 12 years of age do not use dissolve contents of one packet into 8 oz. hot water; sip while hot. Consume entire drink within 10-15 minutes. if using microwave, add contents of one packet to 8 oz. of cool water; stir briskly before and afte...
Dextromethorphan HBr 20 mg
Guaifenesin 400 mg
Do not use
Ask a doctor before use if you have
When using this product
Stop use and ask a doctor if
If pregnant or breast-feeding,
In case of overdose, get medical help or contact a Poison Control Center right away.
do not use more than directed
take every 4 hours. Do not take more than 6 packets in 24 hours.
| Age | Dose |
| adults and children 12 years of age and over | one packet |
| children under 12 years of age | do not use |
acesulfame potassium, anhydrous citric acid, flavor, lactose, maltodextrin, mannitol, povidone K30, silicon dioxide, sodium bicarbonate, sodium chloride, sodium citrate, sucralose, sucrose
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 2176267 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG Powder for Oral Solution | PSN | 1 |
| 2176267 | dextromethorphan hydrobromide 20 MG / guaifenesin 400 MG Powder for Oral Solution | SCD | 1 |
| 2176267 | dextromethorphan HBr 20 MG / guaifenesin 400 MG Powder for Oral Solution | SY | 1 |
| Class | Version | Type | Effective |
|---|---|---|---|
| DEXTROMETHORPHAN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| GUAIFENESIN Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20211129 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 13411-852-06 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-afc5-a426-e053-dadaa90af4c2 | ACETAFLU COUGH & CHEST CONGESTION |
| 13411-852-12 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-afc5-a426-e053-dadaa90af4c2 | ACETAFLU COUGH & CHEST CONGESTION |
| 13411-852-20 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-afc5-a426-e053-dadaa90af4c2 | ACETAFLU COUGH & CHEST CONGESTION |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13411-852-06 | ACETAFLU COUGH AND CHEST CONGESTION | 5 g in 1 PACKET | POWDER | 5 | 1 | |
| 13411-852-06 | ACETAFLU COUGH AND CHEST CONGESTION | 6 in 1 BOX | POWDER | 6 | 1 | |
| 13411-852-12 | ACETAFLU COUGH AND CHEST CONGESTION | 5 g in 1 PACKET | POWDER | 5 | 1 | |
| 13411-852-12 | ACETAFLU COUGH AND CHEST CONGESTION | 12 in 1 BOX | POWDER | 12 | 1 | |
| 13411-852-20 | ACETAFLU COUGH AND CHEST CONGESTION | 5 g in 1 PACKET | POWDER | 5 | 1 | |
| 13411-852-20 | ACETAFLU COUGH AND CHEST CONGESTION | 20 in 1 BOX | POWDER | 20 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 13411-852 | ACETAFLU COUGH AND CHEST CONGESTION (DEXTROMETHORPHAN HBR,GUAIFENESIN) POWDER [ADVANCED PHARMACEUTICAL SERVICES, INC. DBA AFFORDABLE QUALITY PHARMACEUTICALS] | 1 | Legacy NDC, 6 package rows | 20200904_5a6c9b52-255b-48d9-b92e-ded3aa9e29d4.zip |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 13411-852 | 13411-852-06, 13411-852-12, 13411-852-20 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DEXTROMETHORPHAN HYDROBROMIDE | 9D2RTI9KYH | ACTIB |
| GUAIFENESIN | 495W7451VQ | ACTIB |
| ACESULFAME POTASSIUM | 23OV73Q5G9 | IACT |
| ANHYDROUS CITRIC ACID | XF417D3PSL | IACT |
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| MALTODEXTRIN | 7CVR7L4A2D | IACT |
| MANNITOL | 3OWL53L36A | IACT |
| POVIDONE K30 | U725QWY32X | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| SODIUM BICARBONATE | 8MDF5V39QO | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| SODIUM CITRATE | 1Q73Q2JULR | IACT |
| SUCRALOSE | 96K6UQ3ZD4 | IACT |
| SUCROSE | C151H8M554 | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2be60640-112d-4b3f-add3-8ffb74ab21a6 | 5a6c9b52-255b-48d9-b92e-ded3aa9e29d4 | 2020-08-31 | Warnings | 2be60640-112d-4b3f-add3-8ffb74ab21a6 5a6c9b52-255b-48d9-b92e-ded3aa9e29d4 |
Adverse event summaries are temporarily unavailable. Other product information remains available.